1.85
0.00 (0.0%)
0.00 (0.0%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Small Cap Pro
Monthly Subscription
for only
|
|
DDE w/Realtime (Monthly)
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Acer Therapeutics Inc | ACER | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Low Price | High Price | Open Price | Close Price | Last Traded  |
|
|---|---|---|---|---|---|---|---|---|
| 0.00 | 0.0% | 1.85 | 0.00 | 0.00 | 0.00 | 1.85 | 20:00:00 |
| Bid Price | Ask Price | Spread | Spread % | News | |
|---|---|---|---|---|---|
| 1.86 | 2.33 | 0.47 | 20.17% | - | - |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| - | 0 | $ 1.85 | USD |
Acer Therapeutics Financials
| Market Cap | Shares in Issue | Profit/Loss | Earnings Per Share (EPS) | PE Ratio | Float |
|---|---|---|---|---|---|
| $ 18.68M | 10.10M | $ -21.28M | -2.91 | - | 4.65M |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | - |
Acer Therapeutics News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical ACER Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 1.30 | 2.67 | 1.08 | 1.77 | 164,458 | 0.55 | 42.31% |
| 1 Month | 3.28 | 4.0644 | 1.08 | 2.10 | 104,640 | -1.43 | -43.6% |
| 3 Months | 3.60 | 7.25 | 1.08 | 3.51 | 87,698 | -1.75 | -48.61% |
| 6 Months | 3.33 | 7.25 | 1.08 | 3.51 | 68,028 | -1.48 | -44.44% |
| 1 Year | 24.30 | 28.2475 | 1.08 | 5.64 | 137,727 | -22.45 | -92.39% |
| 3 Years | 8.55 | 34.10 | 1.08 | 9.65 | 72,695 | -6.70 | -78.36% |
| 5 Years | 8.55 | 34.10 | 1.08 | 9.65 | 72,695 | -6.70 | -78.36% |
Acer Therapeutics Description
| Acer Therapeutics Inc operates as a pharmaceutical company. Principally, it is focused on the acquisition, development, and commercialization of therapies for patients with serious rare and ultra-rare diseases with a critical unmet medical need. The company's clinical pipeline includes two categories of severe genetic disorders namely EDSIVO for vEDS, and ACER-001 for urea cycle disorders and maple syrup urine disease. |
